1 Section IV Study Designs for Investigating Adaptive Treatment Strategies Murphy.

Slides:



Advertisements
Similar presentations
Postgraduate Course 7. Evidence-based management: Research designs.
Advertisements

Comparator Selection in Observational Comparative Effectiveness Research Prepared for: Agency for Healthcare Research and Quality (AHRQ)
Defining Characteristics
Study Designs in Epidemiologic
Aftercare Attendance Partially Moderated by History of Physical Abuse and Gender Louise F. Haynes 1 ; Amy E. Herrin 1 ; Rickey E. Carter 1 ; Sudie E. Back.
Assessing Program Impact Chapter 8. Impact assessments answer… Does a program really work? Does a program produce desired effects over and above what.
Estimation and Reporting of Heterogeneity of Treatment Effects in Observational Comparative Effectiveness Research Prepared for: Agency for Healthcare.
Experimenting to Improve Clinical Practice S.A. Murphy AAAS, 02/15/13 TexPoint fonts used in EMF. Read the TexPoint manual before you delete this box.:
1 Developing Dynamic Treatment Regimes for Chronic Disorders S.A. Murphy Univ. of Michigan RAND: August, 2005.
Methodology for Adaptive Treatment Strategies for Chronic Disorders: Focus on Pain S.A. Murphy NIH Pain Consortium 5 th Annual Symposium on Advances in.
Experiments and Dynamic Treatment Regimes S.A. Murphy Univ. of Michigan JSM: August, 2005.
SMART Designs for Constructing Adaptive Treatment Strategies S.A. Murphy 15th Annual Duke Nicotine Research Conference September, 2009.
Dynamic Treatment Regimes, STAR*D & Voting D. Lizotte, E. Laber & S. Murphy LSU ---- Geaux Tigers! April 2009.
1.A 33 year old female patient admitted to the ICU with confirmed pulmonary embolism. It was noted that she had elevated serum troponin level. Does this.
Substance Abuse, Multi-Stage Decisions, Generalization Error How are they connected?! S.A. Murphy Univ. of Michigan CMU, Nov., 2004.
An Experimental Paradigm for Developing Dynamic Treatment Regimes S.A. Murphy Univ. of Michigan March, 2004.
SMART Designs for Developing Adaptive Treatment Strategies S.A. Murphy K. Lynch, J. McKay, D. Oslin & T.Ten Have CPDD June, 2005.
Chapter 11: Sequential Clinical Trials Descriptive Exploratory Experimental Describe Find Cause Populations Relationships and Effect Sequential Clinical.
Sizing a Trial for the Development of Adaptive Treatment Strategies Alena I. Oetting The Society for Clinical Trials, 29th Annual Meeting St. Louis, MO.
SMART Experimental Designs for Developing Adaptive Treatment Strategies S.A. Murphy NIDA DESPR February, 2007.
Hypothesis Testing and Dynamic Treatment Regimes S.A. Murphy Schering-Plough Workshop May 2007 TexPoint fonts used in EMF. Read the TexPoint manual before.
An Experimental Paradigm for Developing Adaptive Treatment Strategies S.A. Murphy Univ. of Michigan UNC: November, 2003.
Experiments and Dynamic Treatment Regimes S.A. Murphy Univ. of Michigan PSU, October, 2005 In Honor of Clifford C. Clogg.
Statistical Issues in Developing Adaptive Treatment Strategies for Chronic Disorders S.A. Murphy Univ. of Michigan CDC/ATSDR: March, 2005.
SMART Experimental Designs for Developing Adaptive Treatment Strategies S.A. Murphy RWJ Clinical Scholars Program, UMich April, 2007.
Hypothesis Testing and Dynamic Treatment Regimes S.A. Murphy, L. Gunter & B. Chakraborty ENAR March 2007.
1 SMART Designs for Developing Adaptive Treatment Strategies S.A. Murphy K. Lynch, J. McKay, D. Oslin & T.Ten Have UMichSpline February, 2006.
Dynamic Treatment Regimes, STAR*D & Voting D. Lizotte, E. Laber & S. Murphy ENAR March 2009.
Methodology for Adaptive Treatment Strategies R21 DA S.A. Murphy For MCATS Oct. 8, 2009.
An Experimental Paradigm for Developing Adaptive Treatment Strategies S.A. Murphy Univ. of Michigan ACSIR, July, 2003.
An Experimental Paradigm for Developing Adaptive Treatment Strategies S.A. Murphy Univ. of Michigan February, 2004.
Methods for Estimating the Decision Rules in Dynamic Treatment Regimes S.A. Murphy Univ. of Michigan IBC/ASC: July, 2004.
Discussion of Profs. Robins’ and M  ller’s Papers S.A. Murphy ENAR 2003.
Experiments and Dynamic Treatment Regimes S.A. Murphy Univ. of Michigan April, 2006.
Exploratory Analyses Aimed at Generating Proposals for Individualizing and Adapting Treatment S.A. Murphy BPRU, Hopkins September 22, 2009.
SMART Experimental Designs for Developing Adaptive Treatment Strategies S.A. Murphy ISCTM, 2007.
Experiments and Adaptive Treatment Strategies S.A. Murphy Univ. of Michigan Chicago: May, 2005.
Susan Murphy, PI University of Michigan Acknowledgements: MCAT network and NIH The Goal To facilitate methodological collaborations necessary for producing.
SMART Designs for Developing Dynamic Treatment Regimes S.A. Murphy Symposium on Causal Inference Johns Hopkins, January, 2006.
Adaptive Treatment Strategies S.A. Murphy CCNIA Proposal Meeting 2008.
Adaptive Treatment Strategies S.A. Murphy Workshop on Adaptive Treatment Strategies Convergence, 2008.
Practical Application of Adaptive Treatment Strategies in Trial Design and Analysis S.A. Murphy Center for Clinical Trials Network Classroom Series April.
Hypothesis Testing and Adaptive Treatment Strategies S.A. Murphy SCT May 2007.
Adaptive Treatment Design and Analysis S.A. Murphy TRC, UPenn April, 2007.
John R. Kasich, Governor Tracy Plouck, Director Orman Hall, Director.
Intervention Studies Principles of Epidemiology Lecture 10 Dona Schneider, PhD, MPH, FACE.
Overview of Adaptive Treatment Regimes Sachiko Miyahara Dr. Abdus Wahed.
Moving from Development to Efficacy & Intervention Fidelity Topics National Center for Special Education Research Grantee Meeting: June 28, 2010.
Copyright © 2014 Wolters Kluwer Health | Lippincott Williams & Wilkins Chapter 18 Mixed Methods and Other Special Types of Research.
Copyright © 2008 Wolters Kluwer Health | Lippincott Williams & Wilkins Chapter 12 Undertaking Research for Specific Purposes.
Lecture 16 (Oct 28, 2004)1 Lecture 16: Introduction to the randomized trial Introduction to intervention studies The research question: Efficacy vs effectiveness.
به نام ايزد يکتا Clinical Trial Design Dr. Khalili 1  The common types  Advantages and limitations  Usual applications.
Epidemiology The Basics Only… Adapted with permission from a class presentation developed by Dr. Charles Lynch – University of Iowa, Iowa City.
Background to Adaptive Design Nigel Stallard Professor of Medical Statistics Director of Health Sciences Research Institute Warwick Medical School
Exposure Definition and Measurement in Observational Comparative Effectiveness Research Prepared for: Agency for Healthcare Research and Quality (AHRQ)
Study design P.Olliaro Nov04. Study designs: observational vs. experimental studies What happened?  Case-control study What’s happening?  Cross-sectional.
1 Design and Analysis of Engineering Experiments Chapter 1: Introduction.
BIG 1-98/IBCSG Henning Mouridsen for the BIG 1-98 Collaborative Group Authors: Sunil Verma Date posted: December 22, 2008.
Sequential, Multiple Assignment, Randomized Trials Module 2—Day 1 Getting SMART About Developing Individualized Adaptive Health Interventions Methods Work,
Bayesian Statistics & Innovative Trial Design April 3, 2006 Jane Perlmutter
Experimentation in Computer Science (Part 2). Experimentation in Software Engineering --- Outline  Empirical Strategies  Measurement  Experiment Process.
1 SMART Designs for Developing Adaptive Treatment Strategies S.A. Murphy K. Lynch, J. McKay, D. Oslin & T.Ten Have NDRI April, 2006.
Motivation Using SMART research designs to improve individualized treatments Alena Scott 1, Janet Levy 3, and Susan Murphy 1,2 Institute for Social Research.
An Experimental Paradigm for Developing Adaptive Treatment Strategies S.A. Murphy NIDA Meeting on Treatment and Recovery Processes January, 2004.
SMART Trials for Developing Adaptive Treatment Strategies S.A. Murphy Workshop on Adaptive Treatment Designs NCDEU, 2006.
بسم الله الرحمن الرحیم.
Purpose of Epi Studies Discover factors associated with diseases, physical conditions and behaviors Identify the causal factors Show the efficacy of intervening.
Chapter 6 Selecting a Design. Research Design The overall approach to the study that details all the major components describing how the research will.
CLINICAL PROTOCOL DEVELOPMENT
How Should We Select and Define Trial Estimands
Presentation transcript:

1 Section IV Study Designs for Investigating Adaptive Treatment Strategies Murphy

2 Study Designs for Adaptive Treatments Goal: Develop efficacious and effective adaptive treatment strategies.

3 Study Designs Black Box Study: Randomized comparison between two or more strategies +  Dismantling analyses or  Further dismantling studies.

4 Study Designs Prospectively develop adaptive treatment strategies using  multiple randomized studies or  one sequentially within-person randomized study.

5 Study Designs Equipoise Stratification improve adherence structure future adaptive treatment strategies

6 Our speakers…. Dr. TenHave (Black box and Multiple randomized studies) Dr. Lavori (Equipoise Stratification) Dr. Murphy (Sequential within-person randomized study) Ten Have

7 TenHave: Ten Have

8 Hierarchy of Study Designs Black Box Study Dismantling Analyses - Analysis assumptions unfeasible Unintended negative consequences with burdensome early components Black Box Study Dismantling Studies Prospective Mulitple Studies Equipoise Stratification Sequential Within-person Randomization Analysis assumptions not as unfeasible, but still restrictive - Analysis assumptions very feasible - Patient/provider preference addressed

9 Randomized comparison between two or more adaptive strategies +  Dismantling analyses or  Further dismantling studies. Black Box Studies

10 Black Box Studies Unintended negative effects  Burdensome first component precludes compliance with subsequent components  Significant first component effect negates need to study subsequent components already implemented

11 Black Box Studies Waste funds or suffer reduced power in the first study if the components in the black box treatment are not put together in an optimal way.

12 Black Box Study+ Dismantling Analysis Analysis problems with dismantling individual components Current approaches (SEM, LISREL, PATH, mediator analyses) are observational analyses. More sophisticated approaches still require untestable assumptions.

13 Black Box Study+ Dismantling Studies Can take away first components and see: If the remaining components still produce the effect sizes seen in the black box study If adherence is improved

14 Black Box Study+ Dismantling Studies Black box study may have a null effect due to poor adherence or because some components have negative interactions. Then it may be hard to obtain funding for dismantling studies.

15 Prospective Multiple Studies Prospectively develop adaptive treatment strategies using  Multiple randomized studies or  One sequentially within-person randomized study.

16 Prospective Multiple Studies Discover unintended negative effects prior to running a large scale randomized study of a complex intervention. Optimize our complex intervention. Use prior studies that provide evidence for the primary treatment.

17 Prospective Multiple Studies In contrast to black box studies: Randomization is used at each step to develop the components of an adaptive treatment strategy However, assumptions still needed for investigating a sequence of treatments or a primary treatment followed by maintenance or aftercare treatment.

18 Prospective Multiple Studies Nonetheless, possible benefits: Less waste Higher quality research at each decision step because each step draws the full attention of full study effort A more powerful “final” study of optimized treatment vs. usual care.

19 Phil Lavori:

20 Susan Murphy:

21 Sequentially within-person randomized studies Goal: Estimate best rules for tailoring treatment in an adaptive treatment strategy. Murphy

22 Sequentially within-person randomized studies What are these designs? Why use these designs? What can I do with them? Example

23 What are these designs? At each time, treatment may be changed, randomize individual to one of a class of possible alternatives. –Classes of alternative treatments determined by response to past treatment and other ongoing information.

24 What are these designs? Each individual may be randomized multiple times.

25 Why use these designs? Interactions between subsequent treatments Compositional effects due to prior treatments

26 Why use these designs? Front line treatment experimentally validated only when “usual care” or “treatment as usual” is secondary (aftercare or maintenance) treatment. The sequencing of treatments may make a difference Delayed or Cumulative Effects

27 Why use these designs? Compositional effects are particularly important if we believe that both response to initial treatment and adherence to initial treatment should influence the choice of subsequent treatments.

28 Example of a Study in Development Population: Cocaine abusing women with risky sexual practices. Goal: Reduce risky sexual practices. Subgoal: Find a good treatment strategy to achieve goal!

29

30 What can I do with it? Compare adaptive treatment strategies. There are 4 strategies:

31

32

33 Sequentially Within-Person Randomized Studies CATIE Schizophrenia Study CATIE Alzheimer Study STAR*D ALLHAT

34 STAR*D

35 CATIE

36 To Think About: Could we use these designs to develop “encouragement to adhere” strategies?

37 To Think About: In each design we may restrict the class of secondary treatments based on patient information during initial treatment. What variables should be used to determine the classes of secondary treatments?

38 To Think About: : –Cocaine example uses responder status and adherence to determine the class of treatments. –CATIE uses responder status, tolerance and past treatment to determine the class of treatments. –STAR*D uses responder status, patient/clinical preference and past treatment to determine the class of treatments.

39 To Think About: What are the consequences of restricting the class of treatments? These restrictions structure the resulting adaptive treatment strategies.

40 To Think About: Should any of these designs be followed by a confirmatory randomized control trial; that is, are these designs primarily hypothesis generating and treatment strategy building designs?